tetano
Editor, Senior Moderator
Hypertens Res
. 2022 Dec 23.
doi: 10.1038/s41440-022-01134-5. Online ahead of print.
COVID-19 pandemic and hypertension: an updated report from the Japanese Society of Hypertension project team on COVID-19
Shigeru Shibata[SUP] 1 [/SUP], Kazuo Kobayashi[SUP] 2 3 [/SUP], Masami Tanaka[SUP] 4 [/SUP], Kei Asayama[SUP] 5 [/SUP], Eiichiro Yamamoto[SUP] 6 [/SUP], Hironori Nakagami[SUP] 7 8 [/SUP], Satoshi Hoshide[SUP] 9 [/SUP], Takuya Kishi[SUP] 10 [/SUP], Chisa Matsumoto[SUP] 11 [/SUP], Masaki Mogi[SUP] 12 [/SUP], Satoshi Morimoto[SUP] 13 [/SUP], Koichi Yamamoto[SUP] 14 [/SUP], Masashi Mukoyama[SUP] 15 [/SUP], Kazuomi Kario[SUP] 9 [/SUP], Koichi Node[SUP] 16 [/SUP], Hiromi Rakugi[SUP] 14 [/SUP]
Affiliations
Abstract
The number of reported cases with coronavirus disease 2019 (COVID-19) has exceeded 620 million worldwide, still having a profound impact on people's health and daily lives since its occurrence and outbreak in December 2019. From the early phase of the COVID-19 pandemic, there has been a concern that the rapid spread of this communicable disease can negatively influence non-communicable diseases. Accumulating data indicate that the restriction on the access to medical care, psychological distress, and life-style changes triggered by the pandemic have indeed affected blood pressure control in hypertensive patients. Since our previous report in 2020 that summarized the findings of the literature related to COVID-19 and hypertension, there has been a considerable progress in our understanding of the association between these two disorders; nonetheless, there are remaining challenges and emerging questions in the field. In this article, we aim to summarize the latest information on the impact of the pandemic on blood pressure control, the use of the renin-angiotensin system inhibitors in patients with COVID-19, and the blood pressure changes as one of the possible post-acute sequelae of COVID-19 (also known as long COVID). We also summarize the evidence of telemedicine and COVID-19 vaccination in hypertensive subjects, based on data available as of June 2022.
Keywords: High blood pressure; Long COVID; NCD; RAS inhibitors; SARS-CoV-2.
. 2022 Dec 23.
doi: 10.1038/s41440-022-01134-5. Online ahead of print.
COVID-19 pandemic and hypertension: an updated report from the Japanese Society of Hypertension project team on COVID-19
Shigeru Shibata[SUP] 1 [/SUP], Kazuo Kobayashi[SUP] 2 3 [/SUP], Masami Tanaka[SUP] 4 [/SUP], Kei Asayama[SUP] 5 [/SUP], Eiichiro Yamamoto[SUP] 6 [/SUP], Hironori Nakagami[SUP] 7 8 [/SUP], Satoshi Hoshide[SUP] 9 [/SUP], Takuya Kishi[SUP] 10 [/SUP], Chisa Matsumoto[SUP] 11 [/SUP], Masaki Mogi[SUP] 12 [/SUP], Satoshi Morimoto[SUP] 13 [/SUP], Koichi Yamamoto[SUP] 14 [/SUP], Masashi Mukoyama[SUP] 15 [/SUP], Kazuomi Kario[SUP] 9 [/SUP], Koichi Node[SUP] 16 [/SUP], Hiromi Rakugi[SUP] 14 [/SUP]
Affiliations
- PMID: 36550205
- DOI: 10.1038/s41440-022-01134-5
Abstract
The number of reported cases with coronavirus disease 2019 (COVID-19) has exceeded 620 million worldwide, still having a profound impact on people's health and daily lives since its occurrence and outbreak in December 2019. From the early phase of the COVID-19 pandemic, there has been a concern that the rapid spread of this communicable disease can negatively influence non-communicable diseases. Accumulating data indicate that the restriction on the access to medical care, psychological distress, and life-style changes triggered by the pandemic have indeed affected blood pressure control in hypertensive patients. Since our previous report in 2020 that summarized the findings of the literature related to COVID-19 and hypertension, there has been a considerable progress in our understanding of the association between these two disorders; nonetheless, there are remaining challenges and emerging questions in the field. In this article, we aim to summarize the latest information on the impact of the pandemic on blood pressure control, the use of the renin-angiotensin system inhibitors in patients with COVID-19, and the blood pressure changes as one of the possible post-acute sequelae of COVID-19 (also known as long COVID). We also summarize the evidence of telemedicine and COVID-19 vaccination in hypertensive subjects, based on data available as of June 2022.
Keywords: High blood pressure; Long COVID; NCD; RAS inhibitors; SARS-CoV-2.